{"title":"噬菌体疗法简介;抗生素的替代疗法","authors":"Rameen Atique, Hafiza Arshi Saeed, Bushra Anwar, Tehreem Rana, Ayesha Haidar, Ayesha Muazzam, Areesha Naveed, Javeria Sharif, Aqsa Perveen, Hafiza Rida Fatima, Abdul Samad","doi":"arxiv-2402.10245","DOIUrl":null,"url":null,"abstract":"The term bacteriophage means killer or eater of bacteria. They were initially\ndiscovered by F.W. Twort and later on, Felix d'Herelle unveiled them to the\nworld in 1910. Phage therapy has arisen as a favorable option to conventional\nantibiotics by reducing the multinational problem of increasing antibacterial\nresistance. These virulent viruses particularly prey on and contaminate\nbacterial strains and aid in fighting bacterial diseases. Researchers are\nperforming various clinical trials on the bacteriophage to tackle pathogenic\nbacterial infections, varying from typical illnesses to highly invulnerable\nbiofilms that cannot be treated with antibiotics. The primary experiments\ndemonstrated that phage therapy has fewer consequences than traditional\nantimicrobial drugs. It is safer to use and show results within a few days.\nAlthough phage therapy has a wide range of promising results, but it also\nencounters diverse obstacles. One is that they are host-specific and can merely\nbe used for personalized therapy. As thousands of bacteria can cause disease,\nclinicians have to construct a library of phage viruses. For successful\ntreatment, an analysis of versatility, stability, and immune interference\nrelated to bacteriophage is necessary. Phage therapy is an excellent substitute\nfor antibiotics as it illustrates a living base for the treatment of infections\nand it is climate-friendly. It only targets the pathogenic cells and has less\ninfluence on the normal microbiota. Regardless of the challenges and problems,\nphage therapy is approved as a beneficial approach to combating contagious\ninfections.","PeriodicalId":501219,"journal":{"name":"arXiv - QuanBio - Other Quantitative Biology","volume":"44 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Brief overview on Bacteriophage therapy; Alternative to Antibiotics\",\"authors\":\"Rameen Atique, Hafiza Arshi Saeed, Bushra Anwar, Tehreem Rana, Ayesha Haidar, Ayesha Muazzam, Areesha Naveed, Javeria Sharif, Aqsa Perveen, Hafiza Rida Fatima, Abdul Samad\",\"doi\":\"arxiv-2402.10245\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The term bacteriophage means killer or eater of bacteria. They were initially\\ndiscovered by F.W. Twort and later on, Felix d'Herelle unveiled them to the\\nworld in 1910. Phage therapy has arisen as a favorable option to conventional\\nantibiotics by reducing the multinational problem of increasing antibacterial\\nresistance. These virulent viruses particularly prey on and contaminate\\nbacterial strains and aid in fighting bacterial diseases. Researchers are\\nperforming various clinical trials on the bacteriophage to tackle pathogenic\\nbacterial infections, varying from typical illnesses to highly invulnerable\\nbiofilms that cannot be treated with antibiotics. The primary experiments\\ndemonstrated that phage therapy has fewer consequences than traditional\\nantimicrobial drugs. It is safer to use and show results within a few days.\\nAlthough phage therapy has a wide range of promising results, but it also\\nencounters diverse obstacles. One is that they are host-specific and can merely\\nbe used for personalized therapy. As thousands of bacteria can cause disease,\\nclinicians have to construct a library of phage viruses. For successful\\ntreatment, an analysis of versatility, stability, and immune interference\\nrelated to bacteriophage is necessary. Phage therapy is an excellent substitute\\nfor antibiotics as it illustrates a living base for the treatment of infections\\nand it is climate-friendly. It only targets the pathogenic cells and has less\\ninfluence on the normal microbiota. Regardless of the challenges and problems,\\nphage therapy is approved as a beneficial approach to combating contagious\\ninfections.\",\"PeriodicalId\":501219,\"journal\":{\"name\":\"arXiv - QuanBio - Other Quantitative Biology\",\"volume\":\"44 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"arXiv - QuanBio - Other Quantitative Biology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/arxiv-2402.10245\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"arXiv - QuanBio - Other Quantitative Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/arxiv-2402.10245","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
噬菌体一词的意思是细菌的杀手或食者。噬菌体最初是由 F.W. Twort 发现的,后来 Felix d'Herelle 于 1910 年将其公诸于世。噬菌体疗法的出现减少了抗菌药耐药性不断增强的跨国问题,是传统抗生素的有利选择。噬菌体病毒尤其能捕食和污染细菌菌株,帮助对抗细菌性疾病。研究人员正在对噬菌体进行各种临床试验,以应对病原性细菌感染,包括从典型疾病到无法用抗生素治疗的高致病性生物膜。主要实验证明,噬菌体疗法比传统抗菌药物的后果更少。虽然噬菌体疗法取得了一系列令人鼓舞的成果,但它也遇到了各种各样的障碍。其一,噬菌体具有宿主特异性,只能用于个性化治疗。由于可以致病的细菌成千上万,临床医生必须构建一个噬菌体病毒库。为了成功治疗,有必要对噬菌体的多功能性、稳定性和免疫干扰进行分析。噬菌体疗法是抗生素的绝佳替代品,因为它为治疗感染提供了一个有生命的基础,而且对气候无害。它只针对病原细胞,对正常微生物群的影响较小。无论存在哪些挑战和问题,噬菌体疗法都被认为是抗击传染性感染的有益方法。
Brief overview on Bacteriophage therapy; Alternative to Antibiotics
The term bacteriophage means killer or eater of bacteria. They were initially
discovered by F.W. Twort and later on, Felix d'Herelle unveiled them to the
world in 1910. Phage therapy has arisen as a favorable option to conventional
antibiotics by reducing the multinational problem of increasing antibacterial
resistance. These virulent viruses particularly prey on and contaminate
bacterial strains and aid in fighting bacterial diseases. Researchers are
performing various clinical trials on the bacteriophage to tackle pathogenic
bacterial infections, varying from typical illnesses to highly invulnerable
biofilms that cannot be treated with antibiotics. The primary experiments
demonstrated that phage therapy has fewer consequences than traditional
antimicrobial drugs. It is safer to use and show results within a few days.
Although phage therapy has a wide range of promising results, but it also
encounters diverse obstacles. One is that they are host-specific and can merely
be used for personalized therapy. As thousands of bacteria can cause disease,
clinicians have to construct a library of phage viruses. For successful
treatment, an analysis of versatility, stability, and immune interference
related to bacteriophage is necessary. Phage therapy is an excellent substitute
for antibiotics as it illustrates a living base for the treatment of infections
and it is climate-friendly. It only targets the pathogenic cells and has less
influence on the normal microbiota. Regardless of the challenges and problems,
phage therapy is approved as a beneficial approach to combating contagious
infections.